共 161 条
[1]
Horby P(2021)Dexamethasone in hospitalized patients with Covid-19 N Engl J Med 384 693-704
[2]
Lim WS(2022)Treatment with 3-day methylprednisolone pulses in severe cases of COVID-19 compared with the standard regimen protocol of dexamethasone J Investig Med 70 1423-1428
[3]
Emberson JR(2021)High-dose corticosteroid pulse therapy increases the survival rate in COVID-19 patients at risk of hyper-inflammatory response PLoS ONE 16 e0243964-943
[4]
Mafham M(2020)Risk factors associated with acute respiratory distress syndrome and death in patients with coronavirus disease 2019 pneumonia in Wuhan, China JAMA Intern Med 180 934-123
[5]
Bell JL(2022)Systemic corticosteroids for the treatment of COVID-19: equity-related analyses and update on evidence Cochrane Database Syst Rev 11 CD014963-335
[6]
Dafni M(2021)Mucormycosis: an opportunistic pathogen during COVID-19 Environ Res 201 111643-560
[7]
Karampeli M(2021)Identification of patients with COVID-19 who are optimal for methylprednisolone pulse therapy Multidiscip Respir Med 16 781-482
[8]
Michelakis I(2022)Effectiveness of pulse dose methyl prednisolone in management of COVID 19: a systematic review and meta-analysis of observational studies J Pharm Pharm Sci 25 110-2377
[9]
Manta A(2022)Effect of corticosteroid therapy on mortality in COVID-19 patients—a systematic review and meta-analysis Rev Med Virol 32 e2386-664
[10]
Spanoudaki A(2010)Problem of immortal time bias in cohort studies: example using statins for preventing progression of diabetes BMJ 340 b5087-764